Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Report
  • Published:

Blood tacrolimus concentrations in bone marrow transplant patients undergoing plasmapheresis

Abstract

Microangiopathic hemolytic anemia (MAHA) is a well-described complication of stem cell transplantation. Plasmapheresis is one modality utilized as therapy for patients who develop this complication. However, plasmapheresis may alter whole blood levels of certain medications and its effect on tacrolimus in bone marrow transplant patients is unknown. Because tacrolimus has a narrow therapeutic range, the effect of plasmapheresis on whole blood concentrations would be important to know. We report three allogeneic BMT patients who were receiving tacrolimus as acute GVHD therapy while undergoing plasmapheresis for MAHA. Tacrolimus levels seemed unaffected by plasmapheresis in these patients. Bone Marrow Transplantation (2000) 25, 449–451.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Tzakis AG, Abu-Elmagd K, Fung JJ et al. FK506 rescue in chronic graft-versus-host disease after bone marrow transplantation Transplant Proc 1991 23: 3225–3227

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Koehler MT, Howrie D, Mirro J et al. FK506 (tacrolimus) in the treatment of steroid-resistant acute graft-versus-host disease in children undergoing bone marrow transplantation Bone Marrow Transplant 1995 15: 895–899

    CAS  PubMed  Google Scholar 

  3. Nash R, Etzionir, Storb R et al. Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a single center study Blood 1995 85: 3746–3753

    CAS  PubMed  Google Scholar 

  4. Wingard JR, Nash RA, Przepiorka D et al. Relationship of tacrolimus (FK506) whole blood concentrations and efficacy and safety after JHLA-identical sibling bone marrow transplantation Biol Blood Marrow Transplant 1998 4: 157–163

    Article  CAS  PubMed  Google Scholar 

  5. Pettitt AR, Clark RE . Thrombotic microangiopathy following bone marrow transplantation Bone Marrow Transplant 1994 14: 495–504

    CAS  PubMed  Google Scholar 

  6. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors Transplantation 1974 18: 295–304

    Article  CAS  PubMed  Google Scholar 

  7. Marciniak E, Bailey K, Henslee-Downey PJ, Thompson JS . Bone marrow purging of T lymphocytes with T10B9 monoclonal antibody and complement. In: EM Areman (ed). Bone Marrow and Stem Cell Processing: A Manual of Current Techniques. FA Davis: Philadelphia 1992 pp 208–210

  8. Venkataramanan R . Swaminathan A, Prasad T et al. Clinical pharmacokinetics of tacrolimus Clin Pharmacokinet 1995 29: 404–430

    Article  CAS  PubMed  Google Scholar 

  9. Jusko WJ, Piekoszewski W, Klintmalm GB et al. Pharmacokinetics of tacrolimus in liver transplant patients Clin Pharmacol Ther 1995 57: 281–290

    Article  CAS  PubMed  Google Scholar 

  10. Mekki Q, Lee C, Aweeka F et al. Pharmacokinetics of tacrolimus (FK506) in kidney transplant patients Clin Pharmacol Ther 1995 53: 238 (Abstr.)

    Google Scholar 

  11. Boswell GW, Bekersky I, Fay J et al. Tacrolimus pharmacokinetics in BMT patients Bone Marrow Transplant 1998 21: 23–28

    Article  CAS  PubMed  Google Scholar 

  12. Kershner RP, Fitzsimmons WE . Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation Transplantation 1996 62: 920–926

    Article  CAS  PubMed  Google Scholar 

  13. Winkler M, Ringe B, Baumann J et al. Plasma vs whole blood for therapeutic drug monitoring of patients receiving FK506 for immunosuppression Clin Chem 1994 40: 2247–2253

    CAS  PubMed  Google Scholar 

  14. McMaster P, Mirza DI, Ismail T et al. Therapeutic drug monitoring of tacrolimus in clinical transplantation Ther Drug Monit 1995 17: 602–605

    Article  CAS  PubMed  Google Scholar 

  15. Przepiorka D, Suzuki J, Ippoliti C et al. Blood tacrolimus concentration unchanged by plasmapheresis Am J Hosp Pharm 1994 51: 1708

    CAS  PubMed  Google Scholar 

  16. Jusko WJ, D'Ambrosio R . Monitoring tacrolimus concentrations in plasma and whole blood Trans Proc 1991 23: 2732–2735

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hale, G., Reece, D., Munn, R. et al. Blood tacrolimus concentrations in bone marrow transplant patients undergoing plasmapheresis. Bone Marrow Transplant 25, 449–451 (2000). https://doi.org/10.1038/sj.bmt.1702174

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702174

Keywords

This article is cited by

Search

Quick links